Browse Results

  • Principal Investigator: Wilky, Breelyn

There are 5 clinical trial(s) matching your criteria.


C-700-01: A Phase 1 / 2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second-Line Cervical Cancer

Investigator: Breelyn Wilky

Institutional Protocol #: 20170076

National Clinical Trials Identifier: NCT03104699

Division: Cancer Center

Therapeutic Area: Bone and Soft Tissue Cancers

Phase: Phase I/II

Enrolling Since: 4/10/2017